If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 61 - 70 of 278
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Objective
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Protocol No
GI-YARUR-SPARC
Categories
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults (PREVENTABLE)
Objective
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults
Protocol No
GIM-DUKE-PREVENTABLE
PRECIDENTD: PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Objective
PREvention of Cardovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Protocol No
GIM-PCORI-PRECIDENTD
Categories
The Effect of Housing Instability and Neighborhood Deprivation on Maternal Health - HOME study
Objective
Housing Instability and Neighborhood Deprivation on Maternal Health
Protocol No
IHE-IIT-JDG-HOME
Categories
A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Objective
Eltrekibart in Adults with Moderate to Severe Hidradenitis Suppurativa
Protocol No
DERM-ELILILLY-I7P-MC-DSAF
Categories
A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (RPS) (EORTC-1809: STRASS 2)
Objective
A randomized study investigating preoperative chemotherapy followed by surgery versus surgery alone in patients with high risk retroperitoneal sarcoma (STRASS2)
Protocol No
ECOG-EA7211
A Phase 3, Multicenter, Randomized, Open-Label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects with Relapsed Small Cell Lung Cancer (SCLC) (IDeate-2)
Objective
Study of ifinatamab deruxtecan in subjects with relapsed small cell lung cancer
Protocol No
DAIICHI-DS7300-188
Categories
Adaptive Modification of Neoadjuvant Therapy Based on Clinical Response in Patients with Localized Pancreatic Cancer
Objective
Adaptive Modification of Neoadjuvant Therapy Based on Clinical Response in Patients With Localized Pancreatic Cancer
Protocol No
IIT-TSAI-PANC
Categories
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
Objective
To compare the non-inferiority of bilateral salpingectomy (BLS) with delayed oophorectomy to bilateral salpingo-oophorectomy (BSO) to reduce the risk of ovarian cancer among women with deleterious BRCA1 germline mutations.
Protocol No
NRG-CC008
Categories
A Multi-Center Single Arm Phase II Study to Evaluate the Safety and Efficacy of Genetically Engineered Autologous Cells Expressing Anti-CD20 and Anti-CD19 Specific Chimeric Antigen Receptor in Subjects with Relapsed and/or Refractory Diffuse Large B
Objective
Phase II MB-CART2019.1 for R/R DLBCL
Protocol No
MILTENYI-MB-CART2019-1-DLBCL
Categories